Navigate this market better. Subscribe for FREE stock alerts and information.

Friday, August 1, 2014

Allergan sues Valeant, Ackman for alleged insider trading, (NYSE: AGN), (NYSE: VRX), (TSE: VRX.TO)

Allergan Inc, which is fighting a $51 billion hostile takeover bid from Valeant Pharmaceuticals International and activist investor William Ackman, on Friday filed a federal lawsuit alleging they violated insider trading laws and engaged in other fraudulent practices.

Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 0.96% or $-1.59/share to $164.27. In the past year, the shares have traded as low as $86.95 and as high as $174.49. On average, 2991810 shares of AGN exchange hands on a given day and today's volume is recorded at 814604.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.6% or $-0.7001/share to $116.69. In the past year, the shares have traded as low as $94.55 and as high as $153.10. On average, 3189320 shares of VRX exchange hands on a given day and today's volume is recorded at 2583523.

Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 0.44% or $-0.56/share to $127.27. In the past year, the shares have traded as low as $98.26 and as high as $170.45. On average, 332220 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 218506.



Source